Cynosure to Participate in Leerink Swann Global Healthcare Conference 2014 Fireside Chat to be Webcast Live at 10:45 a.m. (ET) Thursday, February 13
WESTFORD, Mass., Feb. 6, 2014 /PRNewswire/ -- Cynosure, Inc. (NASDAQ: CYNO) today announced that President and Chief Executive Officer Michael Davin and Tim Baker, the Company's Executive Vice President, Chief Operating Officer and Chief Financial Officer, will participate in the Leerink Swann Global Healthcare Conference 2014 in New York City.
The event, which will be conducted in a "fireside chat" format, is scheduled for 10:45 a.m. (ET) Thursday, February 13. Both live and archived audio webcasts of the event will be accessible through a link on the Investor Relations section of the Company's website, www.cynosure.com.
About Cynosure, Inc.
Cynosure develops and markets aesthetic treatment systems that enable plastic surgeons, dermatologists and other medical practitioners to perform non-invasive and minimally invasive procedures to remove hair, treat vascular and benign pigmented lesions, remove multi-colored tattoos, revitalize the skin, liquefy and remove unwanted fat through laser lipolysis, reduce cellulite, clear nails infected by toe fungus and ablate sweat glands. Cynosure's product portfolio is composed of a broad range of energy sources including Alexandrite, diode, Nd: YAG, picosecond, pulse dye, and Q-switched lasers and intense pulsed light. Cynosure sells its products globally under the Cynosure, Palomar and ConBio brand names through a direct sales force in the United States, Canada, Mexico, France, Germany, Spain, the United Kingdom, Australia, China, Japan and Korea, and through international distributors in approximately 100 other countries. For corporate or product information, visit Cynosure's website at www.cynosure.com.
Sharon Merrill Associates, Inc.
SOURCE Cynosure, Inc.